全文获取类型
收费全文 | 35597篇 |
免费 | 2801篇 |
国内免费 | 88篇 |
学科分类
医药卫生 | 38486篇 |
出版年
2022年 | 205篇 |
2021年 | 488篇 |
2020年 | 311篇 |
2019年 | 456篇 |
2018年 | 519篇 |
2017年 | 477篇 |
2016年 | 516篇 |
2015年 | 636篇 |
2014年 | 880篇 |
2013年 | 1354篇 |
2012年 | 1998篇 |
2011年 | 2154篇 |
2010年 | 1268篇 |
2009年 | 1143篇 |
2008年 | 2035篇 |
2007年 | 2029篇 |
2006年 | 2037篇 |
2005年 | 2128篇 |
2004年 | 1956篇 |
2003年 | 1896篇 |
2002年 | 1833篇 |
2001年 | 657篇 |
2000年 | 595篇 |
1999年 | 592篇 |
1998年 | 476篇 |
1997年 | 392篇 |
1996年 | 372篇 |
1995年 | 342篇 |
1994年 | 298篇 |
1993年 | 270篇 |
1992年 | 423篇 |
1991年 | 409篇 |
1990年 | 424篇 |
1989年 | 424篇 |
1988年 | 415篇 |
1987年 | 400篇 |
1986年 | 378篇 |
1985年 | 418篇 |
1984年 | 370篇 |
1983年 | 321篇 |
1982年 | 325篇 |
1981年 | 296篇 |
1980年 | 271篇 |
1979年 | 297篇 |
1978年 | 276篇 |
1977年 | 243篇 |
1976年 | 192篇 |
1975年 | 185篇 |
1974年 | 230篇 |
1973年 | 205篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
102.
Acute normovolaemic haemodilution decreases postoperative allogeneic blood transfusion after total knee replacement 总被引:2,自引:1,他引:1
Olsfanger D.; Fredman B.; Goldstein B.; Shapiro A.; Jedeikin R. 《British journal of anaesthesia》1997,79(3):317-321
We hypothesized that the success of postoperative blood conservation after
acute normovolaemic haemodilution (NVHD) is influenced by the extent of
intraoperative bleeding and surgical trauma, and the timing of autologous
blood transfusion. As total knee replacement is associated with minimal
intraoperative but extensive postoperative blood loss, this procedure is
ideally suited to acute NVHD. Therefore, to test our hypothesis, 30
patients undergoing elective total knee replacement were enrolled in a
prospective, randomized, controlled study. In groups NVHD-2 and NVHD-6,
before induction of anaesthesia patients were bled to a target packed cell
volume (PCV) of 28-30%, and in the post-anaesthesia care unit autologous
blood was transfused over a 2-h period terminating after operation at 2 and
6 h, respectively. In the control group, NVHD was not performed. After
operation, platelets, fibrinogen, prothrombin and partial thromboplastin
time, and liver function, urea and electrolytes were measured and compared
with preoperative baseline values. Significantly (P < 0.024) more
allogeneic blood was transfused in the control group (21 u.) compared with
either group NVHD-2 (7 u.) or group NVHD-6 (5 u.). In the control group,
despite the allogeneic blood transfusion, postoperative PCV decreased until
day 4 after operation. Coagulation profile, liver function and urea and
electrolytes concentrations were unaffected by the method of treatment. We
conclude that for total knee replacement, acute NVHD is an effective blood
conservation strategy. However, there was no difference in allogeneic blood
administration between the two NVHD groups. Coagulation and liver function,
and urea and electrolyte concentrations were unaffected by treatment.
相似文献
103.
Lillian L. L. Leong Marian J. Sturm Yahya Ismail Charlene J. Stephens Roger R. Taylor 《Clinical and experimental pharmacology & physiology》1992,19(2):113-118
1. Phospholipase A2 (PLA2) cleaves phospholipids to produce a lyso-phospholipid and free fatty acid and, in view of the biological activity of the products, PLA2 may play a role in many disease states. Lyso-phospholipids and free arachidonic acid increase in ischaemic myocardium, indicating that ischaemia activates the enzyme. 2. Plasma PLA2 activity was measured in patients with acute myocardial infarction, based on the release of labelled arachidonic acid from Escherichia coli cell membrane. Fourteen males (peak serum creatine phosphokinase (CK) above twice upper normal) were studied on day 1 (within 6 h of chest pain onset), days 2-4, and days 6-9. Normal age matched males (n = 13) were also studied. 3. Plasma PLA2 in patients with uncomplicated myocardial infarction (n = 12) was, initially, 1.14 +/- 0.10 (s.e.m.) nmol/min per mL plasma, similar to that in the normal group (1.52 +/- 0.14). On days 2-4, PLA2 activity increased to 1.94 +/- 0.18 (P less than 0.001) and this activity was correlated with the earlier peak CK level (P less than 0.02). On days 6-9, PLA2 activity was 1.49 +/- 0.13 while in two patients who developed complications and underwent open-heart surgery between the last two measurements, there were further increases to 4.22 and 4.04 nmol/min per mL. 4. The increase in plasma PLA2 in uncomplicated myocardial infarction is likely to be due to release from the damaged myocardium; whether it contributes to pathophysiology is uncertain. 相似文献
104.
105.
106.
107.
Brendan M McGuire Herbert L Bonkovsky Robert L Carithers Raymond T Chung Leonard I Goldstein John R Lake Anna S Lok Carol J Potter Elizabeth Rand Michael D Voigt Pamela R Davis Joseph R Bloomer 《Liver transplantation》2005,11(12):1590-1596
In erythropoietic protoporphyria (EPP), there is excessive production of protoporphyrin, primarily in the bone marrow, resulting in increased biliary excretion of this heme precursor. Some patients will develop progressive liver disease that may ultimately require liver transplantation. However, excessive production of protoporphyrin by the bone marrow continues after transplantation, which may cause recurrent disease in the allograft. This study was performed to define post-transplant survival, the risk of recurrent disease, and specific management issues in patients transplanted for EPP liver disease. The patients studied consisted of twelve males and eight females, with an average age of 31 (range, 13-56) years at the time of transplantation. The estimated maximum MELD score prior to transplant was 21 (range, 15-29). Unique complications in the perioperative period were light induced tissue damage in four patients and neuropathy in six, requiring prolonged mechanical ventilation in four. Patient and graft survival rates were 85% at 1 year, 69% at 5 years, and 47% at 10 years. Recurrent EPP liver disease occurred in 11 of 17 patients (65%) who survived more than 2 months. Three patients were retransplanted at 1.8, 12.6, and 14.5 years after the initial transplant for recurrent EPP liver disease. In conclusion, the 5-year patient survival rate in patients transplanted for EPP liver disease is good, but the recurrence of EPP liver disease appears to diminish long term graft and patient survival. 相似文献
108.
In October 1985, the Food and Drug Administration approved a new indication of aspirin for the secondary prevention of recurrent myocardial infarction (MI) and death in patients with MI or unstable angina. Clinical trials have demonstrated the efficacy of this drug, especially when treatment is begun soon after the initial event. The antiplatelet actions of aspirin seem to be the most plausible explanation for its efficacy in reducing mortality and the rate of reinfarction. A single daily 325-mg tablet is effective and produces side-effect incidences of only zero to two percent above those produced by placebo. This article assesses the current state of knowledge regarding the value of aspirin therapy in survivors of acute MI and the implications for clinical practice. 相似文献
109.
110.